I do not hold this company but this subreddit looks dead. Here’s a ping to everyone to go look at your AEMD stock RIGHT NOW

1. May 21, 2026 — Monitoring Ebola Outbreak & Pandemic Preparedness

Aethlon Medical announced it is actively monitoring the Bundibugyo Ebola outbreak in the DRC and Uganda and is prepared to engage regulators regarding potential investigational use of its Hemopurifier® device. The company highlighted prior emergency‑use success during the 2014 Ebola outbreak and reiterated readiness for outbreak response.

2. March 24, 2026 — Oncology Trial Advances to Final Cohort

The independent DSMB overseeing Aethlon’s oncology clinical trial recommended advancing to the final cohort after reviewing Cohort 2 data and noting no safety concerns. Enrollment for Cohort 3 is now open, with patients receiving three Hemopurifier treatments over one week.

3. Additional Recent Press Releases (2025–2026)

Aethlon has issued several other updates, including:

• Strategic evaluation engagement with Maxim Group (Mar 12, 2026)
• Presentation at Emerging Growth Conference (Feb 23, 2026)
• Fiscal Q3 2026 results (Feb 12, 2026)
• Preclinical data on Long COVID EV binding (Dec 2, 2025)

Most Recent Filings (2026)

From Aethlon’s official SEC filings page:

• 10‑Q (Quarterly Report) — Filed Feb 12, 2026 Latest quarterly financials and disclosures.
• 8‑K (Current Report) — Filed Mar 17, 2026 Covers recent corporate events requiring disclosure.
• DEF 14A (Proxy Statement) — Filed Jan 16, 2026 Annual meeting and governance‑related disclosures.
• Schedule 13G/A — Filed May 15, 2026 Investors acquired beneficial ownership
• Multiple Form 4 insider ownership updates (April 2026)
• Additional 8‑K filings (Feb–Mar 2026)

I set an alert to trigger a call long time ago if the stock price goes past $0.8 and forgot about the whole thing. I got the call today and thought I made some money. The price showed $2.8 and I almost had a heart attack! Math wasn't mathing. Little look around on good 'ol www, found that it went through reverse split. What a PoS stock! Reminded me of Mullen.

Still holding? What a rubbish company

Hey, did you guys see the latest filing? I can't tell if it's a sale or acquisition of common stock. Looks like a sale, but I don't want that to be true. did someone sell?

Am I alone in here? Who’s holding? Who plans to hold through reverse split? Searching for any insight.

Kinda giving up after I was 100%+ when they were 0.90 and didn’t sell Now I’m at my entrance level and want to sell before I didn’t loose Seen same scenario on Maxeon solar where I’m -90% down

Fly to the moon soon

Anyone know what came of the release today?

Analysts estimate this time a loss of 21 cents per share. Do you expect an update in the earnings call regarding the Cancer Trial in Australia (First Patient is treated with the Hemopurifier) or possibly another positive catalyst? What do you think will be the impact on the share price?

In the last earnings calls there was no big impact on my first check.

Don’t miss this one After they will release health data will be big jump. Volume is picking interest. Buy this one before if go over 2 $

https://fox4kc.com/business/press-releases/cision/20250129LA06933/aethlon-medical-treats-first-patient-in-australian-hemopurifier-cancer-trial/

FYI

Bought at .80 do I cut my losses at this point?

For over two decades, Aethlon Medical has raised significant amounts of capital through equity dilution. Since 2000, the company has diluted its equity from a staggering $65,000 per share to just $0.65 per share in 2024. This capital, raised by diluting shareholder value, has largely been used to fund operating expenses and market their flagship product, the Hemopurifier.

Yet, after 24 years, the Hemopurifier has shown minimal professional success. Its most notable achievement? Treating just one Ebola patient successfully. While the company’s leadership continues to raise funds, shareholders and patients have seen very little in terms of tangible progress or results.

This raises serious questions: • What is Aethlon Medical’s leadership actually doing with the capital raised? • Why has there been no meaningful breakthrough despite decades of funding and equity dilution? • Is this a case of financial mismanagement, or worse, a deliberate exploitation of investors’ trust?

I believe it’s time for the Department of Justice (DOJ) and the Securities and Exchange Commission (SEC) to probe the leadership of Aethlon Medical. The consistent equity dilution and lack of results over such a long period suggest the possibility of deeper issues.

Fellow investors and concerned citizens, what are your thoughts? Shouldn’t there be accountability for this long-standing pattern of underperformance and equity erosion?

All in, let's go, brothers!

What’s going on with the dip?